Biolidics Ltd Ordinary Shares 8YY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- SGD 0.01
- Day Range
- SGD 0.01–0.01
- 52-Week Range
- SGD 0.01–0.02
- Bid/Ask
- SGD 0.01 / SGD 0.01
- Market Cap
- SGD 9.34 Mil
- Volume/Avg
- 59,800 / 1.2 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 5.41
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Biolidics Ltd is engaged in research, experimental development, marketing, and distribution of biotechnology, life and medical science, and electronics-related industrial design services and investment holding. Its segments include Cancer; Infectious diseases; and Laboratory services. It derives major revenue from the Laboratory services segment that involves the business, operation, and provision of laboratory services to customers. Its operations are spread across Singapore, Japan, China, Europe, the United States, Hong Kong, the Philippines, Indonesia, and Others.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 26
- Website
- https://www.biolidics.com
Valuation
|
Metric
|
8YY
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 5.41 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
8YY
|
|---|---|
Quick Ratio | 0.15 |
Current Ratio | 0.22 |
Interest Coverage | −21.74 |
Quick Ratio
8YY
Profitability
|
Metric
|
8YY
|
|---|---|
Return on Assets (Normalized) | −64.90% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −294.35% |
Return on Assets
8YY
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Wfdxtxs | Jwfkz | $185.5 Bil | |
SYK
| Stryker Corp | Rndrhvcpvk | Lwb | $128.2 Bil | |
MDT
| Medtronic PLC | Mngkmthhg | Tpyfqlx | $106.7 Bil | |
BSX
| Boston Scientific Corp | Svncdkcn | Lmqvpl | $99.0 Bil | |
DXCM
| DexCom Inc | Hxkdndbs | Zzrb | $53.1 Bil | |
EW
| Edwards Lifesciences Corp | Jwhvgfsz | Fyfsb | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Msrrsbvf | Szs | $24.9 Bil | |
ALGN
| Align Technology Inc | Rykkpcgh | Wxfkwk | $23.5 Bil | |
PHG
| Koninklijke Philips NV ADR | Pqnnxpqb | Zfhbsx | $18.9 Bil | |
PODD
| Insulet Corp | Fgnqprgqgc | Xvmcb | $11.7 Bil |